A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 22, 2014

Primary Completion Date

March 27, 2015

Study Completion Date

October 21, 2016

Conditions
Advanced Solid TumorsRelapsed/Refractory Lymphoma
Interventions
DRUG

Alisertib

Alisertib tablets

DRUG

Itraconazole

Itraconazole oral solution

Trial Locations (4)

Unknown

St Louis

Oklahoma City

Germantown

Dallas

All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY

NCT02259010 - A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma | Biotech Hunter | Biotech Hunter